Navigation Links
Arctic Sun Therapeutic Cooling Device at Center of Heroic Rescue
Date:5/25/2010

LOUISVILLE, Colo., May 25 /PRNewswire/ -- A day after delivering her fourth child at Anaheim Regional Medical Center in Anaheim, California last December, 34-year-old Brynn Ervin suffered a cardiac arrest, the result of massive blood clots lodged in the main arteries that take blood to her lungs.  Desperate to save the life of the young mother, the cardiac arrest team performed 95 minutes of CPR.  Then thoracic surgeon John Eugene, MD operated to remove the blood clots.  Still, Ms. Ervin lay comatose, her neurologic prognosis extremely poor.  The doctors and nurses knew one therapy might save her – therapeutic hypothermia, but Anaheim Regional did not yet own an Arctic Sun® cooling device.  

That's when Anaheim Regional nurses Joan Strydom, April Ponazzo, Alison Legendre and Martha Dispoto jumped into action.  They called Mission Hospital and received permission to borrow an Arctic Sun.  Ms. Strydom personally drove the 65-mile round trip to pick up the machine and its high-tech cooling pads.

By phone, Mission Hospital therapeutic temperature nurse-experts Mary Kay Bader and Teresa Wavra guided the Anaheim Regional nurses over the next several days as they instituted mild hypothermia followed by slow rewarming to protect Ms. Ervin from brain damage.

Two weeks of seizures followed.  But on Christmas day Ms. Ervin uttered her first words.  

At the opening session of this year's American Association of Critical Care Nurses (AACN) annual meeting in Washington DC, incoming president Beth Hammer praised the nurses for their actions, which epitomized the association's theme, Act With Intention.  

"The depth and level of collaboration these nurses acted with to save a patient in an unusually dire situation is breathtaking," Hammer said.

Then Brynn Ervin and her husband Kyle took the stage, having traveled across the country to reunite with, and say thank you to, the caring nurses who saved their family.

"It brought down the house," said Medivance CEO Robert Kline.  "We applaud these heroic healthcare providers who are committed to saving lives.  They overcame enormous obstacles, including lack of experience with our device.  Medivance is the market leader in therapeutic temperature management in good part because of the relative ease and safety with which clinicians can deploy this new therapy.  This story exemplifies how, with a bit of guidance, even first-time users can quickly utilize the non-invasive Arctic Sun and that our product performs well even in the most difficult circumstances."

Cooling a standard of care

Since 2005, when the American Heart Association (AHA) issued recommendations and guidelines for inducing mild hypothermia in comatose survivors of cardiac arrest, adoption of therapeutic cooling has been on the rise.  A rapidly growing body of medical literature suggests it may also reduce damage resulting from refractory fevers and other critical illnesses such as stroke and traumatic brain injury.

About Medivance's Arctic Sun

The noninvasive Arctic Sun Temperature Management System precisely monitors and maintains core body temperature in a therapeutic range, between 32 degrees and 38.5 degrees Celsius (approximately 89.6 degrees to 101.3 degrees Fahrenheit) with the potential to minimize damage to the heart and brain.  The patented design of the Arctic Sun and ArcticGel™ Pads enables the transfer of up to five times more thermal energy than conventional products such as water blankets, wraps or ice packs, resulting in more efficient temperature management.  The system's precision also enables the slow rewarming thought to be critical for therapeutic benefit.  The Arctic Sun has received 510(k) FDA clearance in the U.S., the European Union's CE Mark, and marketing approval in Japan and other global markets.  Medivance develops and manufacturers proprietary Targeted Temperature Management solutions.  www.medivance.com


'/>"/>
SOURCE Medivance
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CryoCath Arctic Front(R) Results Published in JACC
2. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
3. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
4. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
5. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
8. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
9. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
10. Zila Inc. Product Selected to Identify Pre-Cancer in Study of Leading Cancer Treatment Chemotherapeutic - ERBITUX
11. Advanced Life Sciences to Present Data on Selected Cethromycin Therapeutic Studies at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Limited, ( ASX: ITD ), an innovative diversified healthcare company, is ... December 2016 compared with the previous corresponding period. A full "Results ... . Highlights Profit after ... Earnings per share of 2.2 cents (Dec 2015: 1.2 cents; up ... 11%) Profit before tax of $2.12m (Dec 2015: ...
(Date:2/23/2017)... Research and Markets has announced the addition of the "Menopause ... ... Drugs Price Analysis and Strategies - 2016, provides drug pricing data and ... questions: What are the key drugs marketed ... Global Menopause market? What are the unit prices and ...
(Date:2/23/2017)... Research and Markets has announced the addition ... 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs Price ... in the global Oesophageal Cancer market. The research answers ... key drugs marketed for Oesophageal Cancer and their clinical attributes? How ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... ... Indiana Fiber Network (IFN) President and CEO Kelly C. Dyer recently announced that he ... of the Management Committee when IFN was originally formed in 2002 where he was ... development of the business plan. He became the first paid employee of IFN ...
(Date:2/24/2017)... ... February 24, 2017 , ... Castle Farms, the celebrated ... Wedding Giveaway, with the winning couple announced on Feb. 14, 2017, on Facebook. ... from local vendors: A Matter of Taste, Ryan Rousseau Enterprises, A Touch of ...
(Date:2/23/2017)... ... February 23, 2017 , ... The ... funding innovative lymphoma research and serving the lymphoma community through a comprehensive series ... La Gorce Country Club in Miami Beach to host its Swirl: Miami Wine ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Hamlin Dental ... announce that they are sponsoring a raffle. Throughout the month of February, patients who ... receive a gift card for a dinner for two at the Cheesecake Factory. ...
(Date:2/23/2017)... (PRWEB) , ... February 23, 2017 , ... Dr. David ... in Henderson, NV 89052. Dr. Mahon was named a 2017 Top Patient Rated ... is an online directory that recognizes local physicians and dentists who have earned ...
Breaking Medicine News(10 mins):